BioNTech and CEPI partnership to advance mRNA Mpox Vaccine development
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
Luran S MED 797S SPF30 is one of the first ASA materials in the market specifically for medical device housings
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
Free Treatment, investigations and sex change surgery along with other facilities will be available at these OPDs for the Transgender community
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
Public private partnership (PPP) with integrated strategy essential to achieve ‘TB Mukt Bharat’ by 2025
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
Subscribe To Our Newsletter & Stay Updated